marianna.limas

About marianna.limas

This author has not yet filled in any details.
So far marianna.limas has created 48 blog entries.

Ellen Jorgensen

2019-04-25T09:52:53+00:00

Ellen Jorgensen, Co-founder and President of Biotech Without Borders Dr. Ellen Jorgensen is co-founder and President of Biotech Without Borders, a nonprofit organization dedicated to promoting citizen science and access to biotechnology. She is passionate about increasing science literacy in both student and adult populations, particularly in the areas of molecular [...]

Ellen Jorgensen2019-04-25T09:52:53+00:00

Megan Palmer

2019-04-25T09:39:02+00:00

Megan Palmer, Senior Research Scholar at CISAC at Stanford University. Dr. Megan J. Palmer is a Senior Research Scholar at the Center for International Security and Cooperation (CISAC) at Stanford University. She leads a research and practice program on risk governance in emerging technology development, with a focus on how security [...]

Megan Palmer2019-04-25T09:39:02+00:00

David Lips

2019-04-24T04:23:29+00:00

David Lips, Researcher at Spiber David Lips is a researcher at Spiber working on the design and production of protein materials for the next generation of manufacturing applications. One of the leading biotech startups in Japan, Spiber initial targets are the automotive and apparel industries, two huge markets which have the [...]

David Lips2019-04-24T04:23:29+00:00

Keira Havens

2019-04-22T18:02:39+00:00

Keira Havens, Industry and Regulatory Affairs Manager at Pivot Bio. Keira Havens has been deeply involved in synthetic biology as a scientist, an entrepreneur, a communicator, and a thought leader. Her work has engaged all facets of the synthetic biology economy in the pursuit of beautiful biotechnology – well designed, elegant [...]

Keira Havens2019-04-22T18:02:39+00:00

Mike Cox

2019-04-21T13:45:27+00:00

Mike Cox, founder and CEO of Anaerobe Systems. Mike Cox is the founder and CEO of Anaerobe Systems, a microbiology manufacturing and research company. He has a degree in microbiology from the University of Houston. Mike began his career as a medical microbiologist. While working at Stanford University Medical Center he [...]

Mike Cox2019-04-21T13:45:27+00:00

Jason Slingsby

2019-04-18T16:52:26+00:00

Jason Slingsby, Chief Business Officer at Oxford Biomedica. Jason joined Oxford BioMedica in 2015 as Head of Business Development.  He has 20 years experience in the biotechnology industry in biologics, vaccines and gene therapy.  He has worked in international business development roles at Sosei Co., Ltd, and Intercell AG and was [...]

Jason Slingsby2019-04-18T16:52:26+00:00

Sebastian Cocioba

2019-04-17T05:30:48+00:00

Sebastian Cocioba, Co-founder of MicroSynbiotiX. Sebastian Cocioba is a Plant Biotechnology researcher with a focus on the production of commercially and industrially valuable plant species. He is the Co-founder of MicroSynbiotiX, a company that has developed oral vaccines to combat diseases and infections in aquaculture using a novel method using genetically [...]

Sebastian Cocioba2019-04-17T05:30:48+00:00

Ákos Nyerges

2019-04-14T17:34:33+00:00

Ákos Nyerges, Project leader at Csaba Pál Laboratory, Hungarian Academy of Sciences My research targets healthcare and biotechnology with the aid of bacterial synthetic biology. I am advancing the methodological repertoire of genome engineering to understand human health threatening evolutionary processes and allow for a better production of high-value bioproducts. By [...]

Ákos Nyerges2019-04-14T17:34:33+00:00

Josh Silverman

2019-04-10T15:57:36+00:00

Joshua Silverman, CEO of Aromyx Dr. Joshua Silverman serves as CEO for Aromyx, joining the company in 2018.  Dr. Silverman has 20 years of experience in new technology research, development and commercialization.  Dr. Silverman also serves as an advisor for a number of biotechnology companies and was formerly Founder and Chief [...]

Josh Silverman2019-04-10T15:57:36+00:00

Pieter Rottiers

2019-04-10T08:45:03+00:00

Pieter Rottiers, CEO of ActoBio Therapeutics Pieter is CEO of ActoBio Therapeutics™, a clinical-stage biopharmaceutical company developing ActoBiotics®, a new localized therapeutics platform with potential disease-modifying capabilities in auto-immune and allergic diseases. The recent SynBioBeta engineered cell therapy digest featured Pieter discussing living medicines and the ActoBiotics® approach, focusing on AG019, [...]

Pieter Rottiers2019-04-10T08:45:03+00:00